U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949410) titled 'HER2 Vaccine for Locally Advanced Breast Cancer' on April 22.
Brief Summary: The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
HER2-positive Breast Cancer
Intervention:
DRUG: HER2 Vaccine
MVF-HER2 266-296 and MVF HER2 597-626 peptide vaccines
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Pravin T.P Kaumaya
Information provided by (Responsible Party): Pravin T.P Kaumaya, Indiana University
Published by HT Digital Content Services with permission from Health Daily Digest....